← Back to Find a Trial

Recruiting

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Chicago, Illinois · Ages 18–80 · Other · NCT05744336

Periprocedural anxiety is a common problem for patients who undergo interventional pain procedures. Virtual Reality (VR) is an immersive experience that has gained acceptance in the medical field as a tool for reducing anxiety and pain for patients.Research Aim:

To evaluate the effect of immersive virtual reality (VR) on periprocedural anxiety related to therapeutic cervical epidural steroid injections (ESI).

The investigators hypothesize that immersive virtual reality will result in a clinically meaningful anxiety reduction, defined as the proportion of participants with \> 50% reduction in Numeric Rating Scale (NRS) anxiety scores when compared to participants in the non-treatment group who will have standard preprocedural waiting time conditions in clinic, but no VR experience. Similarly, the investigators hypothesize a significant reduction in objective sympathetic tone as measured by skin sympathetic nerve activity (SKNA).

Inclusion Criteria

  • Age 18-80 years old at day of enrollment
  • Neck pain patient deemed to be a candidate for pain control treatment with interventional fluoroscopically guided cervical epidural steroid injection as determined by their pain medicine provider based on history, physical exam, and radiographic findings
  • Willingness to undergo pre-procedural intervention of VR viewing experience or equivalent pre-procedural wait time
  • No history of prior epidural steroid injections
  • Did not receive sedatives prior to or during procedure

Exclusion Criteria

  • Refusal / inability to participate or provide consent
  • Contraindications to injection (anticoagulated states, allergy to components of injection, local infection at injection site, current infectious process or treatment of antibiotics for current infection)
  • Uncontrolled anxiety disorder or untreated/inadequately treated psychiatric disorder
  • History of Alzheimer's, dementia, or cognitive dysfunction
  • Patient currently taking benzodiazepines
  • Severe motion sickness
  • Seizure disorder
  • Vision loss
  • Non-English speaking patients

View official listing on ClinicalTrials.gov ↗

This page is for general information only and is not a guarantee of eligibility or enrollment. Trial details are subject to change — the study site will confirm final eligibility criteria.